Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) tria
scientific article
Author/s
author: Philippe Gabriel Steg, Robert F. Storey, Lars Wallentin, Robert A Harrington, Håkan Emanuelsson, Christopher P Cannon, Hugo A. Katus, Richard C Becker, Stefan James, Steen E Husted, Axel Åkerblom
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.